375 related articles for article (PubMed ID: 30290838)
1. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
[TBL] [Abstract][Full Text] [Related]
2. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
[TBL] [Abstract][Full Text] [Related]
3. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
4. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
5. ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response.
Sagredo EA; Sagredo AI; Blanco A; Rojas De Santiago P; Rivas S; Assar R; Pérez P; Marcelain K; Armisén R
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118716. PubMed ID: 32275931
[TBL] [Abstract][Full Text] [Related]
6. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
7. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.
Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC
Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129
[TBL] [Abstract][Full Text] [Related]
8. RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN.
Park MJ; Jeong E; Lee EJ; Choi HJ; Moon BH; Kang K; Chang S
Mol Cells; 2023 Jun; 46(6):351-359. PubMed ID: 36921992
[TBL] [Abstract][Full Text] [Related]
9. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
10. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
de Santiago PR; Blanco A; Morales F; Marcelain K; Harismendy O; Sjöberg Herrera M; Armisén R
Life Sci; 2021 Mar; 268():118956. PubMed ID: 33383047
[TBL] [Abstract][Full Text] [Related]
11. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
12. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
[TBL] [Abstract][Full Text] [Related]
13. Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing.
Khadka S; Williams CG; Sweeney-Gibbons J; Basler CF
J Virol; 2021 Sep; 95(19):e0065221. PubMed ID: 34346762
[TBL] [Abstract][Full Text] [Related]
14. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
[TBL] [Abstract][Full Text] [Related]
15. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
16. Processing of
Shiromoto Y; Sakurai M; Qu H; Kossenkov AV; Nishikura K
RNA; 2020 Dec; 26(12):1801-1814. PubMed ID: 32817447
[TBL] [Abstract][Full Text] [Related]
17. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
[TBL] [Abstract][Full Text] [Related]
18. Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.
Sharpnack MF; Chen B; Aran D; Kosti I; Sharpnack DD; Carbone DP; Mallick P; Huang K
EBioMedicine; 2018 Jan; 27():167-175. PubMed ID: 29273356
[TBL] [Abstract][Full Text] [Related]
19. ADAR1-mediated regulation of melanoma invasion.
Nemlich Y; Baruch EN; Besser MJ; Shoshan E; Bar-Eli M; Anafi L; Barshack I; Schachter J; Ortenberg R; Markel G
Nat Commun; 2018 May; 9(1):2154. PubMed ID: 29855470
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
